Bracebridge Capital’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
Other funds holding AQST
BCM
Bracebridge Capital's AQST Position: Q2 2026 in Review
Bracebridge Capital held its Aquestive Therapeutics (AQST) position steady in Q2 2026 at 459,216 shares worth $1.91M. The position accounts for 0.03% of the portfolio, ranked #25.
Bracebridge Capital first reported a position in AQST in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.97M in Q4 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.
- Bracebridge Capital held 459,216 shares of Aquestive Therapeutics worth $1.91M as of Q2 2026.
- Bracebridge Capital left its Aquestive Therapeutics share count unchanged in Q2 2026.
- Aquestive Therapeutics made up 0.03% of Bracebridge Capital's portfolio in Q2 2026, its #25 holding.
- Bracebridge Capital first reported a position in Aquestive Therapeutics in Q4 2019 and has held it in 27 quarters since.
- Bracebridge Capital's Aquestive Therapeutics position peaked at $2.97M in Q4 2025.
- 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.
Based on Bracebridge Capital's 13F filing for Q2 2026, filed 14 Aug 2026.